FIELD: chemistry.
SUBSTANCE: invention relates to a compound of the formula given below, or a pharmaceutically acceptable salt thereof, which are suitable for modulating an integrated stress response (ISR) and treating related diseases.
EFFECT: disclosed are prodrug modulators of the integrated stress pathway.
1 cl, 3 tbl, 44 ex
Title | Year | Author | Number |
---|---|---|---|
MODULATORS OF INTEGRATED STRESS SIGNALING PATH | 2017 |
|
RU2769327C2 |
3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND VARIANTS OF THEIR USE | 2018 |
|
RU2795850C2 |
MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS FOR THEIR APPLICATION | 2019 |
|
RU2820540C2 |
3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ZINC FINGER PROTEIN 2 (IKZF2) OF THE IKAROS FAMILY | 2019 |
|
RU2797559C2 |
MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF THEIR APPLICATION | 2019 |
|
RU2797558C2 |
2,5-DISUBSTITUTED ARYLSULPHONAMIDE CCR3 ANTAGONISTS | 2010 |
|
RU2527165C2 |
3-(5-AMINO-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USE THEREOF IN TREATING DISEASES ASSOCIATED WITH ZINC FINGER PROTEIN 2 OF IKAROS (IKZF2) FAMILY | 2019 |
|
RU2815714C2 |
COMPOUND BASED ON PYRROLAMIDOPYRIDONE, METHOD OF ITS PREPARATION AND USE | 2020 |
|
RU2809596C2 |
ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE | 2019 |
|
RU2797622C2 |
TRICYCLIC CONDENSED DERIVATIVES OF PYRIDIN-2-ONE AND USE THEREOF AS BRD4 INHIBITORS | 2016 |
|
RU2734959C2 |
Authors
Dates
2024-08-08—Published
2019-10-11—Filed